Cargando…
Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2
The global COVID-19 pandemic has led to the rapid development of tests for detection of SARS-CoV-2. Studies are required to assess the relative performance of different assays. Here, we compared the performance of two commercial assays, the cobas® SARS-CoV-2 (Roche Diagnostics) and Xpert® Xpress SAR...
Autores principales: | Dust, Kerry, Hedley, Adam, Nichol, Kim, Stein, Derek, Adam, Heather, Karlowsky, James A., Bullard, Jared, Van Caeseele, Paul, Alexander, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482591/ https://www.ncbi.nlm.nih.gov/pubmed/32920028 http://dx.doi.org/10.1016/j.jviromet.2020.113970 |
Ejemplares similares
-
Dorfman pooling enhances SARS-CoV-2 large-scale community testing efficiency
por: Burtniak, Julian, et al.
Publicado: (2023) -
Differential Infectivity of Original and Delta Variants of SARS-CoV-2 in Children Compared to Adults
por: Garnett, Lauren, et al.
Publicado: (2022) -
Comparaison de l’infectivité du coronavirus du syndrome respiratoire aigu sévère 2 chez les enfants et les adultes
por: Bullard, Jared, et al.
Publicado: (2021) -
Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults
por: Bullard, Jared, et al.
Publicado: (2021) -
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
por: Stein, Derek R., et al.
Publicado: (2021)